On Mar. 17, 2021, Tonix Pharma announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox…
On Mar. 17, 2021, the WHO reported that the AstraZeneca COVID-19 vaccine (including Covishield) continued to have a…
On Mar. 16, 2021, Roche announced the launch of the cobasﾮ SARS-CoV-2 Variant Set 1 Test to detect…
On Mar. 16, 2021, AstraZeneca announced it had modified an existing agreement with the US Government to supply…
On Mar. 16, 2021, research from the WHO and partners showed that the COVID-19 pandemic was severely affecting…
On Mar. 16, 2021, Moderna announced that the first participants had been dosed in the Phase 2/3 study,…
On Mar. 15, 2021, Resverlogix announced the publishing of a new article titled: ﾓBromodomain and extraterminal protein inhibitor,…
On Mar. 15, 2021, ImmunityBio announced it had met the safety requirements for the first 12 participants in…
On Mar. 15, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
On Mar. 15, 2021, Moderna announced that the first participants had been dosed in the Phase 1 study…
On Mar. 15, 2021, Altimmune announced additional preclinical data for its single dose intranasal COVID-19 vaccine candidate, AdCOVID….
On Mar. 12, 2021, the WHO listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for…
On Mar. 12, 2021, Johnson & Johnson announced that the World Health Organization (WHO) had issued Emergency Use…
On Mar. 11, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
On Mar. 11, 2021, Altimmune announced that it had expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under…
On Mar. 11, 2021, Novavax announced final efficacy of 96.4% against mild, moderate and severe disease caused by…
On Mar. 11, 2021, Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Mar. 11, 2021, Johnson & Johnson announced that the European Commission (EC) had granted a Conditional Marketing…
On Mar. 11, 2021, the Israel Ministry of Health (MOH), Pfizer and BioNTech announced real-world evidence demonstrating dramatically…
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
On Mar. 10, 2021, TGen, an affiliate of City of Hope, announced the start of a scientific study…
On Mar. 10, 2021, XPhyto and 3a-diagnostics announced successful EN ISO 13485 certification for the rapid point-of-care, SARS-CoV-2…
On Mar. 10, 2021, Innovation Pharmaceuticals announced that a Machine Learning (Artificial Intelligence) model used to screen 1,482…
On Mar. 10, 2021, Thermo Fisher Scientific announced more than $600 million in capital investments to expand its…
On Mar. 9, 2021, PerkinElmer announced the launch of the PerkinElmer COVID-19 Antigen Test for the qualitative detection…
On Mar. 9, 2021, NanoViricides announced that NV-CoV-2 and NV-CoV-2-R were found to be highly effective against a…
On Mar. 9, 2021, Oragenics announced it had entered into a material transfer agreement with Biodextris for the…
On Mar. 9, 2021, VBI Vaccines announced the initiation of enrollment of its Phase 1/2 clinical study of…
On Mar. 10, 2021, Luminex announced that it had submitted an Emergency Use Authorization application to the U.S….
On Mar. 8, 2021, the NIH announced that it had launched the last of three phase 3 clinical…